期刊文献+

人乳头瘤病毒疫苗的研究进展及前景 被引量:4

Progress in research on HPV vaccine and its prospect
下载PDF
导出
摘要 人乳头瘤病毒是宫颈癌的主要致病因子,宫颈癌已成为继乳腺癌之后引起女性死亡的第2大癌症.在一些发展中国家,宫颈癌已居女性癌症死亡率首位.因此,研究开发预防和治疗宫颈癌的疫苗十分必要,该文对近年来人乳头瘤病毒疫苗的研究进展以及前景作以简要综述. Cervical carcinoma is one of the most common gynecological malignant tumors and its prevalence rate is secondary to breast cancer among female' s malignant tumors, even it has ranked the fist one in some developing countries. Human papillomavirus (HPV) is a main pathogenic factor. Therefore, it is necessary to research and develop HPV vaccines to prevent and treat cervical cancer. This article briefly reviewed progress in research on HPV vaccine in recent years and its prospect.
作者 杨博萍 李力
出处 《中国妇幼健康研究》 2010年第6期839-841,共3页 Chinese Journal of Woman and Child Health Research
关键词 人乳头瘤病毒 宫颈癌 疫苗 宫颈上皮内瘤样病变 cervical carcinoma human papillomavirus (HPV) vaccine cervical intraepithelial neoplasia (CIN)
  • 相关文献

参考文献17

  • 1Parkin D M,Bray F,Ferlay J,et al.Global cancer stastistics[J].CA Cancer J Clin,2005,55(2):74-108.
  • 2Saslow D,Castle P E,Cox J T,et al.American cancer society guide line for human papilloma virus(HPV) vaccine use to prevent cervical cancer and its precursors[J].CA Cancer J Clin,2007,57(1):7-28.
  • 3Andrawiss M.Cervical vaccines available in 2007[J].Drug Discov Today,2005,10(14):949-950.
  • 4McLemore M R.Gardasil:Introducing the new human papilloma virus vaccine[J].Clin J Oncol Nurs,2006,10(5):559-560.
  • 5Harper D M,Naud P,Quint W,et al.Sustained immunogenicity and high efficacy against HPV 16/18 related cervical neoplasia:Long-term follow up through 6,4 years in women vaccinated with Cervarix TM(GSK's HPV 16/18 AS04 candidate vaccine)[J].Gynecol Oncol,2008,109(1):158-169.
  • 6Franco E L,Harper D M.Vaccination against human papilloma virus infection:A new paradigm in cervical cancer control[J].Vaccine,2005,23(17-18):2388-2394.
  • 7Mao C,Koutsky L A,Ault K A,et al.Efficacy of human papilloma virus 16 vaccine to prevent cervical intraepithelial neoplasia:A randomized controlled trial[J].Obstet Gynecol,2006,107(1):18-27.
  • 8Kondo K,Ochi H,Matsumoto T,et al.Modification of human papilloma viras-like particle vaccine by insertion of the cross-reactive 12-epitopes[J].J Med Virol,2008,80(5):841-846.
  • 9Cheng W F,Lee C N,Su Y N,et al.Sindbis virus replicon particles encoding calreticulin linked to a tumor antigen generate long term tumor specific immunity[J].Cancer Gene Ther,2006,13(9):8732-8885.
  • 10Santin A D,Bellone S,Palmieri M,et al.HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients witl1 recurrent disease refractory to standard treatment modalities[J].Gynecol Oncol,2006,100(3):469-478.

同被引文献17

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部